Sandra Magalhaes

ORCID: 0000-0003-0061-2720
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Multiple Sclerosis Research Studies
  • Peripheral Neuropathies and Disorders
  • Systemic Lupus Erythematosus Research
  • Fibromyalgia and Chronic Fatigue Syndrome Research
  • Reproductive System and Pregnancy
  • Respiratory viral infections research
  • Neurofibromatosis and Schwannoma Cases
  • Meningioma and schwannoma management
  • Psoriasis: Treatment and Pathogenesis
  • Air Quality and Health Impacts
  • Sleep and related disorders
  • Head and Neck Surgical Oncology
  • Climate Change and Health Impacts
  • Advanced Biosensing Techniques and Applications
  • Sleep and Wakefulness Research
  • Vitamin D Research Studies
  • Ear Surgery and Otitis Media
  • Monoclonal and Polyclonal Antibodies Research
  • Healthcare Policy and Management
  • Health Systems, Economic Evaluations, Quality of Life
  • Suicide and Self-Harm Studies
  • Mental Health and Patient Involvement
  • Indoor Air Quality and Microbial Exposure
  • Soft tissue tumors and treatment
  • Delphi Technique in Research

University of New Brunswick
2018-2025

Government of New Brunswick
2021

McGill University
2010-2018

McGill University Health Centre
2012-2018

Royal Victoria Hospital
2014-2018

Montreal Neurological Institute and Hospital
2011-2014

Imaging Center
2014

Hospital for Sick Children
2009-2014

Royal Victoria Regional Health Centre
2014

Brigham and Women's Hospital
2014

The incidence of acquired demyelination the CNS (acquired demyelinating syndromes [ADS]) in children is unknown. It important that physicians recognize features ADS to facilitate care and appreciate future risk multiple sclerosis (MS).To determine incidence, clinical features, familial autoimmune history, acute management Canadian with ADS.Incidence case-specific data were obtained through Pediatric Surveillance Program from April 1, 2004, March 31, 2007. Before study initiation, a survey...

10.1212/01.wnl.0000339482.84392.bd article EN Neurology 2009-01-19

To study the longitudinal dynamics of anti-myelin oligodendrocyte glycoprotein (MOG) autoantibodies in childhood demyelinating diseases.We addressed kinetics anti-MOG immunoglobulins a prospective comprising 77 pediatric patients. This was supplemented by cross-sectional analyzing 126 patients with acute demyelination and 62 adult multiple sclerosis (MS). MOG-transfected cells were used for detection antibodies flow cytometry.Twenty-five children who immunoglobulin (Ig) positive at disease...

10.1212/wnl.0b013e318228c0b1 article EN Neurology 2011-07-28
Bérengère Aubert-Broche Vladimir Fonov Sridar Narayanan Douglas L. Arnold David Araújo and 94 more Dumitru Fetco Christine Till John G. Sled Brenda Banwell D. Louis Collins Mark Awuku Louise Roberts Janis Baird Nancy Cacciotti Brenda Banwell Amy Waldman Ann Ming Yeh Danielle Boyce Kimberly Carn-Louise Stephanie A. Grover Julia O’Mahony Carmen Yea Melissa McGowan Emily Ursell Sandra Magalhaes Courtney Fairbrother Julia Kennedy Jennifer D. Hamilton Samantha Irwin Amit Bar‐Or Rozie Arnaoutelis Virender Bhan Trudy L. Campbell Lucy Sagar Kelly Sabourin Fran Booth Ruth Ann Marrie Shirley Fredrickson D. A. H. Buckley Dianne McGrath Sharon Penney Mary Connolly Shiela Richards Shelia Kent Vesna Popovska Pamela Cooper Loris Aro Marie-Emmanuelle Dilenge Geneviève Bernard Heather Davies Pat Terrone Asif Doja Daniela Pohl Sunita Venkateswaran Sharon Whiting Chantal Horth Sheila Ledoux François Grand’Maison Julie Lafrenière Simon Levin Vinolia Arthur‐Hayward Mala Ramu Anne Lortie Sophie Morin Fabiola Breault Stéphanie Pellerin Eilidh A. MacDonald Vee McBride Jean K. Mah Jordan Turley Caitlin Wright Natarie Liu Catherine Riddell Brandon Meaney Dave Callen L. Morgenstern Laurie Wyllie Heather B. Neuman David Meek Alison Crowell Noel Lowry Doris Newmeyer Guillaume Sébire Anik Giguère C. Houde Anthony Traboulsee Mário L de Lemos Kati Wambera Colleen Adams Laurie Robson Ellen Wood Elaine Woolridge Edythe Smith Jerome Y. Yager Marjorie Berg Hope Chick Conrad Yim Louise Bentley Lysander Montgomery

To determine the impact of pediatric-onset multiple sclerosis (MS) on age-expected brain growth.Whole and regional volumes 36 patients with relapsing-remitting MS onset prior to 18 years age were segmented in 185 longitudinal MRI scans (2-11 per participant, 3-month 2-year scan intervals). 25 age- sex-matched healthy normal controls (NC) also acquired at baseline 2 later same scanner as group. A total 874 from 339 participants NIH-funded study development intervals used an growth reference....

10.1212/wnl.0000000000001045 article EN Neurology 2014-11-07

Background: Obesity may be a risk factor for developing multiple sclerosis (MS). Objective: We examined if body size influences the of MS in population-based, case control study. Methods: A total 953 cases and 1717 controls from Norway 707 1333 Italy reported their by choosing silhouette 1 to 9 (largest) every fifth year age 5 30 at time The size-related was defined odds ratios (ORs) logistic regression analyses adjusting age, smoking outdoor activity. Results: In large (silhouettes 6–9)...

10.1177/1352458514546785 article EN Multiple Sclerosis Journal 2014-09-02

Objectives: The objective of this paper is to estimate the association between multiple sclerosis (MS) and measures sun exposure in specific age periods Norway Italy. Methods: A total 1660 MS patients 3050 controls from Italy who participated a multinational case-control study (EnvIMS) reported habits during childhood adolescence. Results: significant infrequent summer outdoor activity increased risk was found strongest ages 16 18 years (odds ratio (OR) 1.83, 95% confidence interval (CI)...

10.1177/1352458513513968 article EN Multiple Sclerosis Journal 2014-01-10

Background: Low vitamin D levels have been associated with an increased risk of multiple sclerosis (MS), although it remains unknown whether this relationship varies by age. Objective: The objective paper is to investigate the association between 3 supplementation through cod liver oil at different postnatal ages and MS risk. Methods: In Norwegian component multinational case-control study Environmental Factors Multiple Sclerosis (EnvIMS), a total 953 patients maximum disease duration 10...

10.1177/1352458515578770 article EN cc-by Multiple Sclerosis Journal 2015-05-06

The authors collected demographic, clinical, and neuroimaging data prospectively on 38 children with transverse myelitis. One child died during the illness. female:male ratio was 1.2:1 for under age 10 years 2.6:1 over years. Twenty-eight (74%) reported a prodromal event. Twenty-two patients (58%) had longitudinally extensive myelitis, 9 (24%) focal lesions, 5 (13%) both. Twenty of 33 brain imaging (61%) lesions; 7 fulfilled McDonald criteria dissemination in space. Seven 22 (36%) tested...

10.1177/0883073811420495 article EN Journal of Child Neurology 2011-10-03

Multiple sclerosis (MS) in the pediatric age group is being increasingly recognized. In adults, complex interactions between genetic and environmental factors contribute to risk major component of MS susceptibility localizes histocompatibility (human leukocyte antigen [HLA]). Whether HLA alleles predict at-risk children presenting with acquired demyelinating syndromes (ADS) CNS unknown.HLA-DRB1 were typed using an allele-specific PCR amplification method on samples from 266 ADS enrolled...

10.1212/wnl.0b013e31820ee1cd article EN Neurology 2011-02-03

For most adults with initial clinical presentation of multiple sclerosis (MS), biological disease was likely initiated many years prior. Pediatric-onset MS provides an opportunity to study early processes.Using antigen microarrays, including CNS-related proteins, lipids, and other autoantigens, we studied immunologic events involved in onset pediatric MS. Serum samples were collected at the time incident acquired CNS demyelinating syndromes (ADS) children who, subsequent prospective...

10.1212/wnl.0000000000001066 article EN Neurology 2014-11-08

Several recent studies have found a higher risk of multiple sclerosis (MS) among people with low level education. This has been suggested to reflect an effect smoking and lower vitamin D status in the social class associated levels education.The objective this paper is investigate association between education MS adjusting for known factors smoking, infectious mononucleosis, indicators body size.Within case-control study on Environmental Factors In (EnvIMS), 953 patients 1717 healthy...

10.1177/1352458515579444 article EN cc-by Multiple Sclerosis Journal 2015-05-26

Background: Seasonal fluctuations in solar radiation and vitamin D levels could modulate the immune response against Epstein-Barr virus (EBV) infection influence subsequent risk of multiple sclerosis (MS). Methods: Altogether 1660 MS patients 3050 controls from Norway Italy participating multinational case-control study Environmental Factors In Multiple Sclerosis (EnvIMS) reported season past infectious mononucleosis (IM). Results: IM was generally more frequently ( p=0.002), but associated...

10.1177/1352458513505693 article EN Multiple Sclerosis Journal 2013-09-26

Background: Risk factors for aquaporin-4 (AQP4+) antibody neuromyelitis optica spectrum disorder (NMOSD) are not well-established. Objective: To investigate demographic and environmental associated with NMOSD using a validated questionnaire case–control design. Methods: We enrolled patients AQP4 + through six Canadian Multiple Sclerosis Clinics. Participants completed the Environmental Factors in Study (EnvIMS) questionnaire. Their responses were compared to those of 956 unaffected controls...

10.1177/13524585231151953 article EN cc-by-nc Multiple Sclerosis Journal 2023-02-18

Abstract Objectives Children with medical complexity (CMC) are a population in need of policy and practice reform within the Canadian healthcare system. They generally characterized as sharing four predominant characteristics: (1) one or more complex chronic condition(s), (2) functional limitations, (3) high health resources use, (4) family-identified needs. There is currently no standard method to identify CMC Canada. The aim this research was establish clear select best way population....

10.1093/pch/pxae058 article EN Paediatrics & Child Health 2025-03-20

Background: Results from previous studies on a possible interaction between smoking and Epstein–Barr virus (EBV) in the risk of multiple sclerosis (MS) are conflicting. Objectives: To examine infectious mononucleosis (IM) MS. Methods: Within case–control study Environmental Factors In Multiple Sclerosis (EnvIMS), 1904 MS patients 3694 population-based frequency-matched healthy controls Norway, Italy, Sweden reported prior exposure to history IM. We examined two exposures additive...

10.1177/1352458516671028 article EN Multiple Sclerosis Journal 2016-09-23

Multiple sclerosis (MS) is a chronic disease of the central nervous system, often resulting in significant neurological disability. The causes MS are not known; however, incidence increasing, thereby suggesting that changes lifestyle and/or environmental factors may be responsible. On this background, Environmental Risk Factors Study or EnvIMS study was designed to further explore etiology MS. design and methodology described, providing details enable investigators (i) use our experiences...

10.1159/000381779 article EN Neuroepidemiology 2015-01-01

To describe the neonatal symptoms, developmental problems and chronic multisystem medical morbidities of congenital myotonic dystrophy (CDM) patients registered in United States National Registry Myotonic Dystrophy - a disease-specific, self-report program maintained since 2002. Comparisons with Canadian Paediatric Surveillance Program for CDM are highlighted.Genetically confirmed cases demonstrating symptoms first four weeks life described. Patients (or their caregivers) physicians...

10.1093/pch/15.8.514 article EN Paediatrics & Child Health 2010-10-01

Lower levels of sun exposure in childhood have been suggested to be associated with increased risk multiple sclerosis (MS). In this paper we extend previous work, using two novel analytical strategies.Data collected the Environmental factors MS (EnvIMS) study, a case-control study cases and population-based controls from Canada, Italy Norway, were used. Participants reported on behaviours for 5-year age intervals birth; focused first three (≤15 years). We compared life course epidemiology...

10.1093/ije/dyy269 article EN International Journal of Epidemiology 2018-11-14

Chronic benzodiazepine receptor agonist (BZRA) use among older adults is a public health concern given cognitive and physical risks. One in four New Brunswick, Canada, long-term user of BZRAs. Previous studies using direct-to-patient approach as the primary intervention target have shown promise reducing BZRA use. The Your Answers When Needing Sleep Brunswick (YAWNS NB) study aims to reduce BZRAs increase behavioural therapy for insomnia (CBTi), which recommended first line treatment.The...

10.1016/j.rcsop.2022.100164 article EN cc-by-nc-nd Exploratory Research in Clinical and Social Pharmacy 2022-08-03

Decreasing research funding is in conflict with the increasing need to conduct large studies examine rare risk factors and interactions between factors. As a result, investigators are searching for strategies stretch funds design that will maximize investments already made. Multiple sclerosis (MS) generally accepted as multifactorial disease, assessment of desire assess within particular sub-groups requires number participants. Harmonization methodology may help address this problem....

10.1111/ane.12031 article EN Acta Neurologica Scandinavica 2012-12-01

Importance Direct-to-patient interventions enabling transitions from long-term benzodiazepine receptor agonist (BZRA) use to cognitive behavioral therapy for insomnia (CBTI) by older adults has the potential reduce BZRA and related harms while improving sleep outcomes without requiring prearranged clinician involvement. Objective To compare 2 direct-to-patient behavior change with treatment as usual (TAU) on use, sleep, other health outcomes, uptake of CBTI techniques. Design, Setting,...

10.1001/jamapsychiatry.2024.2731 article EN JAMA Psychiatry 2024-09-18

A paralisia de Bell é uma facial unilateral início súbito e causa desconhecida. Pode afetar a salivação, o paladar lacrimejamento dependendo do topografia acometimento nervo facial, os pacientes podem referir hipersensibilidade auditiva. Nos com Bell, reflexo estapediano está ausente. OBJETIVO: O objetivo desta investigação foi verificar se apresentam hiperacusia. FORMA DE ESTUDO: Clínico prospectivo. MATERIAL E MÉTODO: Foram examinados 18 aleatórios apresentando periférica Bell. Foi...

10.1590/s0034-72992004000600012 article PT Revista Brasileira de Otorrinolaringologia 2004-12-01
Coming Soon ...